Equities

SymBio Pharmaceuticals Ltd

SymBio Pharmaceuticals Ltd

Actions
  • Price (USD)1.21
  • Today's Change0.00 / 0.00%
  • Shares traded20.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Aug 21 2024 19:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Dec 31 202320232022
OPERATIONS
Net income(1195)2,106
Depreciation/depletion9698
Non-Cash items432(439)
Cash taxes paid, supplemental355364
Cash interest paid, supplemental----
Changes in working capital472(138)
Total cash from operations(195)1,628
INVESTING
Capital expenditures(233)(48)
Other investing and cash flow items, total(144)0.43
Total cash from investing(377)(47)
FINANCING
Financing cash flow items(12)(32)
Total cash dividends paid----
Issuance (retirement) of stock, net692660
Issuance (retirement) of debt, net----
Total cash from financing680628
NET CHANGE IN CASH
Foreign exchange effects126214
Net change in cash2342,422
Net cash-begin balance/reserved for future use6,2833,860
Net cash-end balance/reserved for future use6,5176,283
SUPPLEMENTAL INCOME
Depreciation, supplemental9698
Cash interest paid, supplemental----
Cash taxes paid, supplemental355364
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.